Clinical Trial Update: Effects of DPP-4 Inhibition on Triglycerides [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of DPP-4 inhibition on triglyceride levels in patients with type 2 diabetes and hypertriglyceridemia is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Oregon Health and Science University | Conditions: Type 2 Diabetes, Hypertriglyceridemia | Phase 4 | Status: SUSPENDED